Bradley Foster & Sargent’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $588K | Buy |
+6,165
| New | +$592K | 0.01% | 386 |
|
|
2025
Q4 | – | Sell |
-1,959
| Closed | -$242K | – | 530 |
|
|
2025
Q3 | $242K | Sell |
1,959
-175
| -8% | -$21.7K | ﹤0.01% | 501 |
|
|
2025
Q2 | $256K | Hold |
2,134
| – | – | ﹤0.01% | 484 |
|
|
2025
Q1 | $314K | Sell |
2,134
-265
| -11% | -$40.5K | 0.01% | 398 |
|
|
2024
Q4 | $390K | Buy |
2,399
+983
| +69% | +$161K | 0.01% | 385 |
|
|
2024
Q3 | $231K | Buy |
+1,416
| New | +$210K | ﹤0.01% | 439 |
|
|
2024
Q2 | – | Sell |
-1,556
| Closed | -$238K | – | 451 |
|
|
2024
Q1 | $238K | Hold |
1,556
| – | – | ﹤0.01% | 416 |
|
|
2023
Q4 | $222K | Sell |
1,556
-4,149
| -73% | -$553K | ﹤0.01% | 414 |
|
|
2023
Q3 | $907K | Hold |
5,705
| – | – | 0.02% | 276 |
|
|
2023
Q2 | $907K | Sell |
5,705
-240
| -4% | -$38.7K | 0.02% | 276 |
|
|
2023
Q1 | $941K | Sell |
5,945
-2
| -0% | -$300 | 0.02% | 255 |
|
|
2022
Q4 | $835K | Sell |
5,947
-100
| -2% | -$14.2K | 0.02% | 265 |
|
|
2022
Q3 | $776K | Sell |
6,047
-1
| -0% | -$144 | 0.02% | 260 |
|
|
2022
Q2 | $853K | Sell |
6,048
-61
| -1% | -$8.71K | 0.02% | 255 |
|
|
2022
Q1 | $849K | Sell |
6,109
-390
| -6% | -$59.8K | 0.02% | 279 |
|
|
2021
Q4 | $1.13M | Buy |
6,499
+4,336
| +200% | +$723K | 0.02% | 234 |
|
|
2021
Q3 | $358K | Buy |
2,163
+19
| +0.9% | +$3.27K | 0.01% | 344 |
|
|
2021
Q2 | $386K | Sell |
2,144
-800
| -27% | -$146K | 0.01% | 333 |
|
|
2021
Q1 | $568K | Sell |
2,944
-2,010
| -41% | -$387K | 0.01% | 275 |
|
|
2020
Q4 | $1M | Buy |
4,954
+100
| +2% | +$20.7K | 0.03% | 224 |
|
|
2020
Q3 | $1.02M | Buy |
+4,854
| New | +$1.08M | 0.03% | 202 |
|
|
2020
Q1 | $841K | Buy |
4,852
+152
| +3% | +$25.1K | 0.03% | 192 |
|
|
2019
Q4 | $722K | Buy |
4,700
+51
| +1% | +$7.62K | 0.02% | 245 |
|
|
2019
Q3 | $706K | Buy |
4,649
+1,000
| +27% | +$158K | 0.02% | 232 |
|
|
2019
Q2 | $559K | Sell |
3,649
-6,900
| -65% | -$1.05M | 0.02% | 255 |
|
|
2019
Q1 | $1.69M | Buy |
10,549
+1,000
| +10% | +$155K | 0.06% | 178 |
|
|
2018
Q4 | $1.47M | Buy |
9,549
+7,200
| +307% | +$1.12M | 0.06% | 178 |
|
|
2018
Q3 | $353K | Hold |
2,349
| – | – | 0.01% | 308 |
|
|
2018
Q2 | $318K | Hold |
2,349
| – | – | 0.01% | 313 |
|
|
2018
Q1 | $313K | Sell |
2,349
-50
| -2% | -$6.72K | 0.01% | 304 |
|
|
2017
Q4 | $357K | Sell |
2,399
-175
| -7% | -$23.8K | 0.01% | 288 |
|
|
2017
Q3 | $340K | Hold |
2,574
| – | – | 0.01% | 291 |
|
|
2017
Q2 | $343K | Buy |
2,574
+455
| +21% | +$61.4K | 0.01% | 292 |
|
|
2017
Q1 | $286K | Hold |
2,119
| – | – | 0.01% | 305 |
|
|
2016
Q4 | $254K | Buy |
2,119
+60
| +3% | +$7.08K | 0.01% | 312 |
|
|
2016
Q3 | $258K | Buy |
+2,059
| New | +$270K | 0.01% | 312 |
|
Other funds holding CLX
Bradley Foster & Sargent's CLX Position: Q2 2026 in Review
Bradley Foster & Sargent opened a new position in Clorox (CLX) in Q2 2026: 6,165 shares worth $588K. The stake represents 0.01% of the portfolio and ranks #386 among its holdings. This is a return to the name: Bradley Foster & Sargent previously reported a position in CLX as recently as Q3 2025.
Bradley Foster & Sargent first reported a position in CLX in Q3 2016 and has held it in 36 quarters since. The position peaked at $1.69M in Q1 2019. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Bradley Foster & Sargent held 6,165 shares of Clorox worth $588K as of Q2 2026.
- Clorox was a new Bradley Foster & Sargent position in Q2 2026.
- Clorox made up 0.01% of Bradley Foster & Sargent's portfolio in Q2 2026, its #386 holding.
- Bradley Foster & Sargent first reported a position in Clorox in Q3 2016 and has held it in 36 quarters since.
- Bradley Foster & Sargent's Clorox position peaked at $1.69M in Q1 2019.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.